ALNYLAM PHARMACEUTICALS, INC. Annual Costs and Expenses in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2016 to 2023.
  • Alnylam Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $578M, a 7.67% increase year-over-year.
  • Alnylam Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $2.28B, a 9.86% increase year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $2.11B, a 15.8% increase from 2022.
  • Alnylam Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $1.82B, a 17.4% increase from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $1.55B, a 17.5% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.11B +$288M +15.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $1.82B +$270M +17.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $1.55B +$232M +17.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $1.32B +$162M +14% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $1.16B +$270M +30.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-10
2018 $890M +$300M +50.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $590M +$118M +25.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $472M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.